Peptides
GLP-1 Showdown: Tirzepatide, Semaglutide, and a New Weekly Contender
A network meta-analysis finally ranks the incretin heavyweights head-to-head, while a novel once-weekly peptide files its first big numbers. Here's what the data actually shows.